Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20030050648 A1
Publication typeApplication
Application numberUS 09/951,105
Publication dateMar 13, 2003
Filing dateSep 11, 2001
Priority dateSep 11, 2001
Also published asCA2459702A1, CA2459702C, DE60230638D1, EP1424970A2, EP1424970A4, EP1424970B1, EP2078502A2, EP2078502A3, US7757692, US8414655, US8974484, US20040206349, US20040211412, US20040243140, US20050033310, US20090205667, US20110054632, US20130345737, US20160030049, WO2003022124A2, WO2003022124A3
Publication number09951105, 951105, US 2003/0050648 A1, US 2003/050648 A1, US 20030050648 A1, US 20030050648A1, US 2003050648 A1, US 2003050648A1, US-A1-20030050648, US-A1-2003050648, US2003/0050648A1, US2003/050648A1, US20030050648 A1, US20030050648A1, US2003050648 A1, US2003050648A1
InventorsClifton Alferness, Hugo Gonzalez, David Dillard
Original AssigneeSpiration, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Removable lung reduction devices, systems, and methods
US 20030050648 A1
Abstract
An air passageway obstruction device includes a frame structure and a flexible membrane overlying the frame structure. The frame structure is collapsible upon advancement of the device into the air passageway, expandable into a rigid structure upon deploying in the air passageway and recollapsible upon removal from the air passageway. The flexible membrane obstructs inhaled air flow into a lung portion communicating with the air passageway. The device may be removed after deployment in an air passageway by recollapsing the device and pulling the device proximally through a catheter.
Images(8)
Previous page
Next page
Claims(32)
What is claimed is:
1. A device for reducing the size of a lung comprising an obstructing structure dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the obstructing structure having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung, the obstructing structure being collapsible to permit removal of the obstruction device from the air passageway.
2. The device of claim 1 wherein the obstructing structure forms a one-way valve.
3. The device of claim 1 further including at least one anchor that anchors the device within the air passageway when the device is deployed and wherein the at least one anchor is releasable during collapse of the obstructing structure and removal of the device from the air passageway.
4. The device of claim 1 wherein the obstructing structure includes a collapsible frame and a flexible membrane overlying the collapsible frame.
5. The device of claim 4 wherein the flexible membrane has an opened proximal end and a closed distal end.
6. The device of claim 5 wherein the flexible membrane inflates to inhaled air to preclude air from flowing into the lung portion and at least partially deflates to exhaled air to permit air to flow from the lung portion.
7. The device of claim 4 wherein the collapsible frame includes at least one anchor that anchors the device within the air passageway when deployed and wherein the at least one anchor is releasable during collapse of the collapsible frame and removal of the device from the air passageway.
8. An assembly comprising:
a device for reducing the size of a lung, the device being dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the device having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung;
a catheter having an internal lumen and being configured to be passed down a trachea, into the air passageway; and
a retractor dimensioned to be passed down the internal lumen of the catheter, seizing the device, and pulling the obstruction device proximally into the internal lumen to remove the device from the air passageway,
the device being collapsible after having been deployed to permit the device to be pulled proximally into the internal lumen of the catheter by the retractor.
9. The assembly of claim 8 wherein the device is collapsible by the catheter as the device is pulled into the internal lumen of the catheter by the retractor.
10. The assembly of claim 8 wherein the retractor includes collapsing means for collapsing the device before pulling the device into the internal lumen of the catheter.
11. The assembly of claim 8 wherein the device is a one-way valve.
12. The assembly of claim 8 wherein the device further includes at least one anchor that anchors the device within the air passageway when the device is deployed and wherein the at least one anchor is releasable as the device is pulled proximally into the internal lumen of the catheter and collapsed for removal from the air passageway.
13. The assembly of claim 8 wherein the device includes a collapsible frame and a flexible membrane overlying the collapsible frame.
14. The assembly of claim 13 wherein the flexible membrane has an opened proximal end and a closed distal end.
15. The assembly of claim 14 wherein the flexible membrane inflates to inhaled air to preclude air from flowing into the lung portion and at least partially deflates to exhaled air to permit air to flow from the lung portion.
16. The assembly of claim 13 wherein the collapsible frame includes at least one anchor that anchors the device within the air passageway when deployed and wherein the at least one anchor is releasable during collapse of the collapsible frame and removal of the device from the air passageway.
17. A method of removing a deployed air passageway obstruction device from an air passageway in which the device is deployed, the method including the steps of:
passing a catheter, having an internal lumen, down a trachea and into the air passageway;
advancing a retractor down the internal lumen of the catheter to the device;
seizing the device with the retractor;
collapsing the device to free the device from deployment in the air passageway; and
pulling the device with the retractor proximally into the internal lumen of the catheter.
18. The method of claim 17 wherein the collapsing step is performed as the device is pulled into the internal lumen of the catheter.
19. The method of claim 18 wherein the device is collapsed by the catheter.
20. The method of claim 19 wherein the device is collapsed by the internal lumen of the catheter.
21. The method of claim 17 wherein the device is collapsed prior to being pulled into the internal lumen of the catheter.
22. The method of claim 21 wherein the device is collapsed by the retractor.
23. The method of claim 17 wherein the device includes at least one anchor for fixing the device in the air passageway when deployed and wherein the collapsing step includes the step of releasing the at least one anchor from the air passageway.
24. An air passageway obstruction device comprising:
a frame structure; and
a flexible membrane overlying the frame structure,
the frame structure being collapsible upon advancement of the device into the air passageway, expandable into a rigid structure upon deployment in the air passageway whereby the flexible membrane obstructs inhaled air flow into a lung portion communicating with the air passageway, and recollapsible upon removal from the air passageway.
25. The device of claim 24 wherein the frame structure and flexible membrane form a one-way valve.
26. The device of claim 25 wherein the flexible membrane inflates to inhaled air to obstruct the air passageway and at least partially deflates to exhaled air to at least partially unobstruct the air passageway.
27. The device of claim 24 wherein the frame structure includes at least one anchor that engages and fixes the device in the air passageway upon deployment.
28. The device of claim 27 wherein the at least one anchor is releasable from engagement with the air passageway upon recollapse of the frame structure.
29. An air passageway obstruction device comprising:
frame means for forming a support structure; and
flexible membrane means overlying the support structure,
the frame means being expandable to an expanded state within an air passageway to position the membrane means for obstructing air flow within the air passageway and being collapsible for removal of the device from the air passageway.
30. The device of claim 29 wherein the frame means and flexible membrane means form a one-way valve when the frame means is in the expanded state.
31. The device of claim 29 wherein the frame means further includes anchor means for fixing the device in the air passageway when the frame means is in the expanded state.
32. The device of claim 31 wherein the anchor means releases the device from the air passageway when the frame means collapses for removal of the device from the air passageway.
Description
    BACKGROUND OF THE INVENTION
  • [0001]
    The present invention is generally directed to a treatment of Chronic Obstructive Pulmonary Disease (COPD). The present invention is more particularly directed to removable air passageway obstruction devices, and systems and methods for removing the devices.
  • [0002]
    Chronic Obstructive Pulmonary Disease (COPD) has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.
  • [0003]
    The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991 COPD was the fourth leading cause of death in the United States and had increased 33% since 1979.
  • [0004]
    COPD affects the patients whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking up hill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time.
  • [0005]
    COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
  • [0006]
    The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.
  • [0007]
    Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled β-agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
  • [0008]
    About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the procedure was abandoned.
  • [0009]
    The lung volume reduction surgery (LVRS) was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor due to the fact that Medicare stopping reimbursing for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. What data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life. However, the surgery is not without potential complications. Lung tissue is very thin and fragile. Hence, it is difficult to suture after sectioning. This gives rise to potential infection and air leaks. In fact, nearly thirty percent (30%) of such surgeries result in air leaks.
  • [0010]
    Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory muscaulature, and improved right ventricular filling.
  • [0011]
    Lastly, lung transplantation is also an option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients.
  • [0012]
    In view of the need in the art for new and improved therapies for COPD which provide more permanent results than pharmacotherapy while being less invasive and traumatic than LVRS, at least two new therapies have recently been proposed.
  • [0013]
    Both of these new therapies provide lung size reduction by permanently collapsing at least a portion of a lung.
  • [0014]
    In accordance with a first one of these therapies, and as described in U.S. Pat. No. 6,258,100 assigned to the assignee of the present invention and incorporated herein by reference, a lung may be collapsed by obstructing an air passageway communicating with the lung portion to be collapsed. The air passageway may be obstructed by placing an obstructing member in the air passageway. The obstructing member may be a plug-like device which precludes air flow in both directions or a one-way valve which permits air to be exhaled from the lung portion to be collapsed while precluding air from being inhaled into the lung portion. Once the air passageway is sealed, the residual air within the lung will be absorbed over time to cause the lung portion to collapse.
  • [0015]
    As further described in U.S. Pat. No. 6,258,100, the lung portion may be collapsed by inserting a conduit into the air passageway communicating with the lung portion to be collapsed. An obstruction device, such as a one-way valve is then advanced down the conduit into the air passageway. The obstruction device is then deployed in the air passageway for sealing the air passageway and causing the lung portion to be collapsed.
  • [0016]
    The second therapy is fully described in copending U.S. application Ser. No. 09/534,244, filed Mar. 23, 2000, for LUNG CONSTRICTION APPARATUS AND METHOD and, is also assigned to the assignee of the present invention. As described therein, a lung constriction device including a sleeve of elastic material is configured to cover at least a portion of a lung. The sleeve has a pair of opened ends to permit the lung portion to be drawn into the sleeve. Once drawn therein, the lung portion is constricted by the sleeve to reduce the size of the lung portion.
  • [0017]
    Both therapies hold great promise for treating COPD. Neither therapy requires sectioning and suturing of lung tissue.
  • [0018]
    While either therapy alone would be effective in providing lung size reduction and treatment of COPD, it has recently been proposed that the therapies may be combined for more effective treatment. More specifically, it has been proposed that the therapies could be administered in series, with the first mentioned therapy first applied acutely for evaluation of the effectiveness of lung size reduction in a patient and which lung portions should be reduced in size to obtain the best results. The first therapy is ideal for this as it is noninvasive and could be administered in a physician's office. Once the effectiveness of lung size reduction is confirmed and the identity of the lung portions to be collapsed is determined, the more invasive second mentioned therapy may be administered.
  • [0019]
    In order to combine these therapies, or simply administer the first therapy for evaluation, it will be necessary for at least some of the deployed air passageway obstruction devices to be removable. Unfortunately, such devices as currently known in the art are not suited for removal. While such devices are expandable for permanent deployment, such devices are not configured or adapted for recollapse after having once been deployed in an air passageway to facilitate removal. Hence, there is a need in the art for air passageway obstruction devices which are removable after having been deployed and systems and methods for removing them.
  • SUMMARY OF THE INVENTION
  • [0020]
    The invention provides device for reducing the size of a lung comprising an obstructing structure dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the obstructing structure having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung, the obstructing structure being collapsible to permit removal of the obstruction device from the air passageway.
  • [0021]
    The invention further provides an assembly comprising a device for reducing the size of a lung, the device being dimensioned for insertion into an air passageway communicating with a portion of the lung to be reduced in size, the device having an outer dimension which is so dimensioned when deployed in the air passageway to preclude air from flowing into the lung portion to collapse the portion of the lung for reducing the size of the lung, a catheter having an internal lumen and being configured to be passed down a trachea, into the air passageway, and a retractor dimensioned to be passed down the internal lumen of the catheter, seizing the device, and pulling the obstruction device proximally into the internal lumen to remove the device from the air passageway. The device is collapsible after having been deployed to permit the device to be pulled proximally into the internal lumen of the catheter by the retractor.
  • [0022]
    The invention further provides a method of removing a deployed air passageway obstruction device from an air passageway in which the device is deployed. The method includes the steps of passing a catheter, having an internal lumen, down a trachea and into the air passageway, advancing a retractor down the internal lumen of the catheter to the device, seizing the device with the retractor, collapsing the device to free the device from deployment in the air passageway, and pulling the device with the retractor proximally into the internal lumen of the catheter.
  • [0023]
    The invention still further provides an air passageway obstruction device comprising a frame structure, and a flexible membrane overlying the frame structure. The frame structure is collapsible upon advancement of the device into the air passageway, expandable into a rigid structure upon deployment in the air passageway whereby the flexible membrane obstructs inhaled air flow into a lung portion communicating with the air passageway, and re-collapsible upon removal from the air passageway.
  • [0024]
    The invention still further provides an air passageway obstruction device comprising frame means for forming a support structure, and flexible membrane means overlying the support structure. The frame means is expandable to an expanded state within an air passageway to position the membrane means for obstructing air flow within the air passageway and is collapsible for removal of the device from the air passageway.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0025]
    The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like referenced numerals identify identical elements, and wherein:
  • [0026]
    [0026]FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system;
  • [0027]
    [0027]FIG. 2 is a sectional view similar to FIG. 1 but illustrating a respiratory system suffering from COPD and the execution of a first step in treating the COPD condition in accordance with the present invention;
  • [0028]
    [0028]FIG. 3 is a perspective view, illustrating the frame structure of a removable air passageway obstruction device embodying the present invention;
  • [0029]
    [0029]FIG. 4 is a perspective view of the complete air passageway obstruction device of FIG. 3;
  • [0030]
    [0030]FIG. 5 is an end view of the device of FIG. 3 illustrating its operation for obstructing inhaled air flow;
  • [0031]
    [0031]FIG. 6 is another end view of the device of FIG. 3 illustrating its operation for permitting exhaled air flow;
  • [0032]
    [0032]FIG. 7 is a perspective view of the device of FIG. 3, illustrating its operation for permitting partial exhaled air flow;
  • [0033]
    [0033]FIG. 8 is a side view illustrating a first step in removing the device of FIG. 3 in accordance with one embodiment of the present invention;
  • [0034]
    [0034]FIG. 9 is another side view illustrating the collapse of the device of FIG. 3 as it is removed from an air passageway;
  • [0035]
    [0035]FIG. 10 is a side view illustrating an initial step in the removal of the device of FIG. 3 in accordance with another embodiment of the present invention;
  • [0036]
    [0036]FIG. 11 is a side view illustrating engagement of the frame structure of the device with a catheter during removal of the device;
  • [0037]
    [0037]FIG. 12 is a side view illustrating the collapse of the device by the catheter during removal of the device;
  • [0038]
    [0038]FIG. 13 is a side view of another air passageway obstruction device embodying the present invention during an initial step in its removal from an air passageway;
  • [0039]
    [0039]FIG. 14 is another side view of the device of FIG. 13 illustrating its collapse during removal from the air passageway;
  • [0040]
    [0040]FIG. 15 is a perspective view of the frame structure of another removable air passageway obstruction device embodying the present invention;
  • [0041]
    [0041]FIG. 16 is a cross-sectional side view of the device of FIG. 15 shown in a deployed state;
  • [0042]
    [0042]FIG. 17 is a perspective side view of the device of FIG. 15 shown in a deployed state;
  • [0043]
    [0043]FIG. 18 is a side view illustrating an initial step in removing the device of FIG. 15 from an air passageway;
  • [0044]
    [0044]FIG. 19 is a side view illustrating an intermediate step in the removal of the device of FIG. 15; and
  • [0045]
    [0045]FIG. 20 is a side view illustrating the collapse of the device of FIG. 15 during its removal from an air passageway.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0046]
    Referring now to FIG. 1, it is a sectional view of a healthy respiratory system. The respiratory system 20 resides within the thorax 22 which occupies a space defined by the chest wall 24 and the diaphragm 26.
  • [0047]
    The respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, the bronchial branches 34, 36, 38, 40, and 42 and sub-branches 44, 46, 48, and 50. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60. Each bronchial branch and sub-branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof. As used herein, the term “air passageway” is meant to denote either a bronchial branch or sub-branch which communicates with a corresponding individual lung lobe or lung lobe portion to provide inhaled air thereto or conduct exhaled air therefrom.
  • [0048]
    Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
  • [0049]
    In contrast to the healthy respiratory system of FIG. 1, FIG. 2 illustrates a respiratory system suffering from COPD. Here it may be seen that the lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight. Hence, this individual is incapable of breathing normally by moving the diaphragm 28. Instead, in order to create the negative pressure in the thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths. It has been found that the apex portion 62 and 66 of the upper lung lobes 52 and 56, respectively, are most affected by COPD.
  • [0050]
    In accordance with this embodiment of the present invention, COPD treatment or evaluation is initiated by feeding a conduit or catheter 70 down the trachea 28, into a mainstream bronchus such as the right mainstem bronchus 32, and into an air passageway such as the bronchial branch 42 or the bronchial sub-branch 50. An air passageway obstruction device embodying the present invention is then advanced down an internal lumen 71 of the catheter 70 for deployment in the air passageway. Once deployed, the obstruction device precludes inhaled air from entering the lung portion to be collapsed. In accordance with the present invention, it is preferable that the obstruction device take the form of a one-way valve. In addition to precluding inhaled air from entering the lung portion, the device further allows air within the lung portion to be exhaled. This results in more rapid collapse of the lung portion. However, obstruction devices which preclude both inhaled and exhaled air flow are contemplated as falling within the scope of the invention.
  • [0051]
    The catheter 70 is preferably formed of flexible material such as polyethylene. Also, the catheter 70 is preferably preformed with a bend 72 to assist the feeding of the catheter from the right mainstem bronchus 32 into the bronchial branch 42.
  • [0052]
    [0052]FIGS. 3 and 4 show an air passageway obstruction device 80 embodying the present invention. The device 80 includes a proximal end 82 and a distal end 84. The device 80 further includes a frame structure 86 including frame supports 88, 90, and 92.
  • [0053]
    Each of the frame supports has a shape to define a generally cylindrical center portion 94 and a pair of oppositely extending inwardly arcuate conical end portions 96 and 98. The frame structure further includes a plurality of fixation members 100, 102, and 104 which extend distally from the proximal end 82. The fixation members have the generally conical shape and terminate in fixation projections or anchors 106, 108, and 110 which extend radially outwardly.
  • [0054]
    Overlying and partially enclosing the frame structure 86 is a flexible membrane 112. The flexible membrane extends over the generally cylindrical and conical portions 94 and 98 defined by the frame structure. Hence, the flexible membrane is opened in the proximal direction.
  • [0055]
    The flexible membrane may be formed of silicone or polyurethane, for example. It may be secured to the frame structure in a manner known in the art such as by crimping, riveting, or adhesion.
  • [0056]
    The frame structure 86 and the device 80 are illustrated in FIGS. 3 and 4 as the device would appear when fully deployed in an air passageway. The frame structure supports and frame structure fixation members are preferably formed of stainless steel or Nitinol or other suitable material which has memory of an original shape. The frame structure permits the device to be collapsed for advancement down the internal lumen 71 of the catheter 70 into the air passageway where the device is to be deployed. Once the point of deployment is reached, the device is expelled from the catheter to assume its original shape in the air passageway. In doing so, the generally cylindrical portion 94 contacts the inner wall of the air passageway and the fixation projections 106, 108, and 110 pierce the wall of the air passageway for fixing or anchoring the device 80 within the air passageway.
  • [0057]
    When the device 80 is deployed, the frame structure 86 and flexible membrane 112 form an obstructing structure or one-way valve. FIGS. 5 and 6 show the valve action of the device 80 when deployed in an air passageway, such as the bronchial branch 42.
  • [0058]
    As shown in FIG. 5, during inhalation, the flexible membrane is filled with air and expands outwardly to obstruct the air passageway 42. This precludes air from entering the lung portion being collapsed. However, as shown in FIG. 6, during expiration, the flexible membrane 112 deflects inwardly to only partially obstruct the air passageway 42. This enables air, which may be in the lung portion being collapsed, to be exhaled for more rapid collapse of the lung portion. FIG. 7 is another view showing the device 80 during expiration with a portion 114 of the membrane 112 deflected inwardly.
  • [0059]
    [0059]FIGS. 8 and 9 illustrate a manner in which the device 80 may be removed from the air passageway 42 in accordance with one embodiment of the present invention. As previously mentioned, it may be desired to remove the device 80 if it is only used for evaluating the effectiveness of collapsing a lung portion or if it is found the more effective treatment may be had with the collapse of other lung portions.
  • [0060]
    The device 80 is shown in FIG. 8 in a fully deployed state. The catheter 70 having the internal lumen 71 is advanced to the proximal end of the device 80. In FIG. 8 it may be noted that the fixation members 102 and 104 define a larger conical radius than the frame supports 88 and 90. Hence, when the proximal end of the device is engaged by a retractor and the catheter 70 is moved distally as shown in FIG. 9, the internal lumen of the catheter engages the fixation members 102 and 104 before it engages the frame supports 88 and 90. This causes the fixation projections to first disengage the inner wall of the air passageway 42. With the device now free of the air passageway side wall, the retractor may be used to pull the device into the internal lumen 71 of the catheter 70 causing the support structure and thus the device to collapse. The collapsed device may now fully enter the internal lumen of the catheter for removal.
  • [0061]
    FIGS. 10-12 show another embodiment of the present invention for removing the device 80 from the air passageway 42. Here, the catheter 70 is fed down a bronchoscope 118 to the device 80. The retractor takes the form of a forceps 120.
  • [0062]
    In FIG. 10 it may be seen that the forceps has just engaged the proximal end 82 of the device 80. In FIG. 11 the forceps 120 is held stationary while the catheter 70 is advanced distally so that the internal lumen 71 of the catheter 70 engages the fixation members 102 and 104. Further advancement of the catheter 70 as seen in FIG. 12 deflects the fixation projections 110 and 108 inwardly away from the inner wall of the air passageway 42. Now, the forceps may be used to pull the device 80 into the internal lumen 71 of the catheter 70 for removal of the device 80 from the air passageway 42.
  • [0063]
    [0063]FIGS. 13 and 14 show another removable air passageway obstruction device 130 and a method of removing it from an air passageway in accordance with the present invention. The device 130 is shown in FIG. 13 deployed in the air passageway 42 and the catheter 70 is in ready position to remove the device 130 from the air passageway 42.
  • [0064]
    The device 130 is of similar configuration to the device 80 previously described. Here however, the fixation members 136 and 138 are extensions of the frame supports 132 and 134, respectively. To that end, it will be noted in FIG. 13 that the frame supports 132 and 134 cross at a pivot point 140 at the distal end 142 of the device 130. They extend distally and then are turned back at an acute angle to terminate at fixation or anchor ends 146 and 148. When the device is deployed as shown in FIG. 13, the cylindrical portions of the support frame engage the inner wall of the air passageway 42 and the fixation points 146 and 148 project into the inner wall of the air passageway 42 to maintain the device in a fixed position. The flexible membrane 150 extends from the dashed line 152 to the pivot or crossing point 140 of the frame supports 132 and 134 to form a one-way valve.
  • [0065]
    When the device is to be removed, the frame structure of the device 130 is held stationary by a retractor within the catheter 70 and the catheter is advanced distally. When the catheter 70 engages the frame supports 132 and 134, the frame supports are deflected inwardly from their dashed line positions to their solid line positions. This also causes the fixation members 136 and 138 to be deflected inwardly from their dashed line positions to their solid line positions in the direction of arrows 154. These actions disengage the device 130 from the inner wall of the air passageway 42. Now, the retractor may pull the device into the internal lumen 71 of the catheter 70 for removal of the device 130 from the air passageway 42.
  • [0066]
    FIGS. 15-17 show a still further removable air passageway obstruction device 160 embodying the present invention. As shown in the initial collapsed state in FIG. 15, the device 160 includes a plurality of frame supports 162, 164, 166, and 168. The frame supports extend between a proximal ring 170 and a distal ring 172. The device 160 is preferably laser cut from a sheet of Nitinol.
  • [0067]
    Since each of the frame supports are identical, only frame support 164 will be described herein. As will be noted, the support 164 includes a bend point 174 with a relatively long section 176 extending distally from the bend point 174 and a relatively short section 178 extending proximally from the bend point 174. The short section 178 includes a fixation projection or anchor 180 extending slightly distally from the bend point 174.
  • [0068]
    [0068]FIGS. 16 and 17 show the device 160 in its deployed configuration. When the device is deployed, it is advanced down a catheter to its deployment site in its collapsed state as shown in FIG. 15. When the deployment site is reached, the device 160 is held outside of the catheter and the rings 170 and 172 are pulled toward each other. This causes the device to bend at the bend points of the frame supports. This forms fixation projections 180, 182, and 184 extending into the inner wall of the air passageway to fix the device in position.
  • [0069]
    The relatively long sections of the frame supports are covered with a flexible membrane 186 as shown in FIGS. 16 and 17 to form a one-way valve. The valve functions as previously described to obstruct inhaled air flow but to permit exhaled air flow.
  • [0070]
    FIGS. 18-20 illustrate a manner of removing the device 160 from an air passageway. Once again a catheter 70 is advanced down a bronchoscope 118 to the device 160. Next, a retractor including a forceps 120 and pin 190 are advanced to the device. The pin 190, carrying a larger diameter disk 192, extends into the device as the forceps 120 grasps the proximal ring 170 of the device 160. The pin 190 continues to advance until the disk 192 engages the distal ring 172 of the device 160 as shown in FIG. 19. Then, while the forceps 120 holds the proximal ring 170, the pin 190 and disk 192 are advanced distally carrying the distal ring 172 distally. This causes the device 160 to straighten and collapse as shown in FIG. 20. Now, the forceps 120, pin 190, and the device 160 may be pulled into the internal lumen 71 of the catheter 70 for removal of the device. As will be appreciated by those skilled in the art, the foregoing steps may be reversed for deploying the device 160.
  • [0071]
    While particular embodiments of the present invention have been shown and described, modifications may be made, and it is therefore intended in the appended claims to cover all such changes and modifications which fall within the true spirit and scope of the invention.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2832078 *Oct 17, 1956Apr 29, 1958Battelle Memorial InstituteHeart valve
US2981254 *Nov 12, 1957Apr 25, 1961Vanderbilt Edwin GApparatus for the gas deflation of an animal's stomach
US3320972 *Apr 16, 1964May 23, 1967High Roy FProsthetic tricuspid valve and method of and device for fabricating same
US3445916 *Apr 19, 1967May 27, 1969Schulte Rudolf RMethod for making an anatomical check valve
US3472230 *Dec 19, 1966Oct 14, 1969Fogarty T JUmbrella catheter
US3617060 *Apr 10, 1967Nov 2, 1971Iezzi WarrenPneumothorox-inducing hunting arrow
US3657744 *May 8, 1970Apr 25, 1972Univ MinnesotaMethod for fixing prosthetic implants in a living body
US3671979 *Sep 23, 1969Jun 27, 1972Univ UtahCatheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US3757783 *Sep 24, 1971Sep 11, 1973Sherwood Medical Ind IncSuction drainage apparatus
US3760808 *Dec 1, 1969Sep 25, 1973Bleuer KTampon applicator assembly
US3788327 *Mar 30, 1971Jan 29, 1974Donowitz HSurgical implant device
US4014318 *May 22, 1975Mar 29, 1977Dockum James MCirculatory assist device and system
US4056854 *Sep 28, 1976Nov 8, 1977The United States Of America As Represented By The Department Of Health, Education And WelfareAortic heart valve catheter
US4084268 *Apr 22, 1976Apr 18, 1978Shiley Laboratories, IncorporatedProsthetic tissue heart valve
US4086665 *Dec 16, 1976May 2, 1978Thermo Electron CorporationArtificial blood conduit
US4212463 *Feb 17, 1978Jul 15, 1980Pratt Enoch BHumane bleeder arrow
US4218782 *May 19, 1978Aug 26, 1980Biocoating AnpartsselskabHeart valve prosthesis and method for the production thereof
US4222126 *Dec 14, 1978Sep 16, 1980The United States Of America As Represented By The Secretary Of The Department Of Health, Education & WelfareUnitized three leaflet heart valve
US4250873 *Apr 17, 1978Feb 17, 1981Richard Wolf GmbhEndoscopes
US4302854 *Jun 4, 1980Dec 1, 1981Runge Thomas MElectrically activated ferromagnetic/diamagnetic vascular shunt for left ventricular assist
US4339831 *Mar 27, 1981Jul 20, 1982Medtronic, Inc.Dynamic annulus heart valve and reconstruction ring
US4619246 *May 20, 1985Oct 28, 1986William Cook, Europe A/SCollapsible filter basket
US4681110 *Dec 2, 1985Jul 21, 1987Wiktor Dominik MCatheter arrangement having a blood vessel liner, and method of using it
US4710192 *Oct 17, 1986Dec 1, 1987Liotta Domingo SDiaphragm and method for occlusion of the descending thoracic aorta
US4732152 *Dec 5, 1985Mar 22, 1988Medinvent S.A.Device for implantation and a method of implantation in a vessel using such device
US4759758 *Dec 7, 1984Jul 26, 1988Shlomo GabbayProsthetic heart valve
US4795449 *Aug 4, 1986Jan 3, 1989Hollister IncorporatedFemale urinary incontinence device
US4808183 *Jun 3, 1980Feb 28, 1989University Of Iowa Research FoundationVoice button prosthesis and method for installing same
US4819664 *Feb 17, 1988Apr 11, 1989Stefano NazariDevice for selective bronchial intubation and separate lung ventilation, particularly during anesthesia, intensive therapy and reanimation
US4830003 *Jun 17, 1988May 16, 1989Wolff Rodney GCompressive stent and delivery system
US4832680 *Jul 3, 1986May 23, 1989C.R. Bard, Inc.Apparatus for hypodermically implanting a genitourinary prosthesis
US4846836 *Oct 3, 1988Jul 11, 1989Reich Jonathan DArtificial lower gastrointestinal valve
US4850999 *May 26, 1981Jul 25, 1989Institute Fur Textil-Und Faserforschung Of StuttgartFlexible hollow organ
US4852568 *Dec 28, 1987Aug 1, 1989Kensey Nash CorporationMethod and apparatus for sealing an opening in tissue of a living being
US4877025 *Oct 6, 1988Oct 31, 1989Hanson Donald WTracheostomy tube valve apparatus
US4934999 *Jul 28, 1988Jun 19, 1990Paul BaderClosure for a male urethra
US4968294 *Feb 9, 1989Nov 6, 1990Salama Fouad AUrinary control valve and method of using same
US5061274 *Dec 4, 1989Oct 29, 1991Kensey Nash CorporationPlug device for sealing openings and method of use
US5116360 *Dec 27, 1990May 26, 1992Corvita CorporationMesh composite graft
US5116564 *Oct 10, 1989May 26, 1992Josef JansenMethod of producing a closing member having flexible closing elements, especially a heart valve
US5123919 *Nov 21, 1991Jun 23, 1992Carbomedics, Inc.Combined prosthetic aortic heart valve and vascular graft
US5151105 *Oct 7, 1991Sep 29, 1992Kwan Gett CliffordCollapsible vessel sleeve implant
US5158548 *Jul 24, 1991Oct 27, 1992Advanced Cardiovascular Systems, Inc.Method and system for stent delivery
US5161524 *Aug 2, 1991Nov 10, 1992Glaxo Inc.Dosage inhalator with air flow velocity regulating means
US5283063 *Jan 31, 1992Feb 1, 1994Eagle VisionPunctum plug method and apparatus
US5304199 *Jan 4, 1993Apr 19, 1994Gene E. Myers Enterprises, Inc.Apparatus for arterial total occlusion plaque separation
US5306234 *Mar 23, 1993Apr 26, 1994Johnson W DudleyMethod for closing an atrial appendage
US5314473 *Jan 5, 1993May 24, 1994Godin Norman JProsthesis for preventing gastric reflux into the esophagus
US5352240 *May 31, 1989Oct 4, 1994Promedica International, Inc.Human heart valve replacement with porcine pulmonary valve
US5358518 *Jan 25, 1993Oct 25, 1994Sante CamilliArtificial venous valve
US5366478 *Jul 27, 1993Nov 22, 1994Ethicon, Inc.Endoscopic surgical sealing device
US5382261 *Sep 1, 1992Jan 17, 1995Expandable Grafts PartnershipMethod and apparatus for occluding vessels
US5392775 *Mar 22, 1994Feb 28, 1995Adkins, Jr.; Claude N.Duckbill valve for a tracheostomy tube that permits speech
US5409019 *Nov 3, 1993Apr 25, 1995Wilk; Peter J.Coronary artery by-pass method
US5411507 *Jan 5, 1994May 2, 1995Richard Wolf GmbhInstrument for implanting and extracting stents
US5411552 *Jun 14, 1994May 2, 1995Andersen; Henning R.Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5453090 *Mar 1, 1994Sep 26, 1995Cordis CorporationMethod of stent delivery through an elongate softenable sheath
US5507754 *Aug 20, 1993Apr 16, 1996United States Surgical CorporationApparatus and method for applying and adjusting an anchoring device
US5509900 *Oct 15, 1993Apr 23, 1996Kirkman; Thomas R.Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5603698 *Aug 23, 1995Feb 18, 1997Boston Scientific CorporationProsthesis delivery system
US5803078 *May 26, 1995Sep 8, 1998Brauner; Mark E.Methods and apparatus for intrapulmonary therapy and drug administration
US5833694 *May 16, 1997Nov 10, 1998Medtronic, Inc.Stent assembly and method of use
US5925063 *Sep 26, 1997Jul 20, 1999Khosravi; FarhadCoiled sheet valve, filter or occlusive device and methods of use
US5954636 *Jul 15, 1997Sep 21, 1999Schwartz; Roy E.Pediatric endotracheal tube with bronchial blocker and method for selectively blocking respiratory airflow to a pediatric patient's lung
US6010525 *Aug 1, 1997Jan 4, 2000Peter M. BonuttiMethod and apparatus for securing a suture
US6132458 *May 15, 1998Oct 17, 2000American Medical Systems, Inc.Method and device for loading a stent
US6149664 *Aug 27, 1998Nov 21, 2000Micrus CorporationShape memory pusher introducer for vasoocclusive devices
US6165179 *Aug 2, 1999Dec 26, 2000Boston Scientific CorporationVena cava delivery system
US6203551 *Oct 4, 1999Mar 20, 2001Advanced Cardiovascular Systems, Inc.Chamber for applying therapeutic substances to an implant device
US6267775 *Mar 6, 2000Jul 31, 2001Schneider (Usa) Inc.Self-expanding medical device for centering radioactive treatment sources in body vessels
US6283334 *Aug 30, 1999Sep 4, 2001Kimberly-Clark Worldwide, Inc.Personal dispensing system
US6293951 *Aug 24, 1999Sep 25, 2001Spiration, Inc.Lung reduction device, system, and method
US6425916 *Feb 10, 1999Jul 30, 2002Michi E. GarrisonMethods and devices for implanting cardiac valves
US6447530 *Nov 25, 1997Sep 10, 2002Scimed Life Systems, Inc.Atraumatic anchoring and disengagement mechanism for permanent implant device
US6471718 *Oct 16, 2000Oct 29, 2002American Medical Systems, Inc.Method and device for loading a stent
US6527761 *Oct 27, 2000Mar 4, 2003Pulmonx, Inc.Methods and devices for obstructing and aspirating lung tissue segments
US6558429 *Mar 26, 2001May 6, 2003Reflux CorporationPerorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof
US6694979 *Mar 2, 2001Feb 24, 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6860847 *Jul 10, 2001Mar 1, 2005Spiration, Inc.Constriction device viewable under X ray fluoroscopy
US6904909 *Nov 22, 2002Jun 14, 2005Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US20010010017 *Feb 28, 2001Jul 26, 2001Brice LetacAlve prosthesis for implantation in body channels
US20010037808 *Mar 2, 2001Nov 8, 2001Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20020052626 *Apr 20, 2001May 2, 2002Paul GilsonEmbolic protection system
US20020112729 *Feb 21, 2001Aug 22, 2002Spiration, Inc.Intra-bronchial obstructing device that controls biological interaction with the patient
US20030018922 *Jul 18, 2001Jan 23, 2003Litwin Louis RobertMethod and system for providing emergency shutdown of a malfunctioning device
US20030019385 *Sep 11, 2002Jan 30, 2003Leasure John D.Subsonic cartridge for gas-operated automatic and semiautomatic weapons
US20030167065 *Mar 1, 2002Sep 4, 2003Arvik Enterprises, LlcBlood vessel occlusion device
US20030181922 *Mar 20, 2002Sep 25, 2003Spiration, Inc.Removable anchored lung volume reduction devices and methods
US20030183235 *Apr 17, 2003Oct 2, 2003Spiration, Inc.Bronchial obstruction device deployment system and method
US20030212412 *May 9, 2002Nov 13, 2003Spiration, Inc.Intra-bronchial obstructing device that permits mucus transport
US20030216769 *May 17, 2002Nov 20, 2003Dillard David H.Removable anchored lung volume reduction devices and methods
US20040167636 *Dec 22, 2003Aug 26, 2004Dillard David H.Methods of achieving lung volume reduction with removable anchored devices
US20040173282 *Jun 28, 2002Sep 9, 2004Thomas LaetgaardInflating unit with sealing facilities for a tyre filled with air
US20040206349 *May 17, 2004Oct 21, 2004Alferness Clifton A.Removable lung reduction devices, systems, and methods
US20040210248 *Mar 12, 2003Oct 21, 2004Spiration, Inc.Apparatus, method and assembly for delivery of intra-bronchial devices
US20040211412 *May 17, 2004Oct 28, 2004Alferness Clifton A.Removable lung reduction devices, systems, and method
US20040243140 *May 18, 2004Dec 2, 2004Alferness Clifton A.Collapsible intra-bronchial valve devices
US20050033310 *May 17, 2004Feb 10, 2005Alferness Clifton A.Intra-bronchial valve devices
US20050033344 *Sep 3, 2004Feb 10, 2005Dillard David H.One-way valve devices for anchored implantation in a lung
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6679264Mar 4, 2000Jan 20, 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6722360Jun 14, 2001Apr 20, 2004Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US6997189Jul 28, 2003Feb 14, 2006Broncus Technologies, Inc.Method for lung volume reduction
US7334581Apr 19, 2004Feb 26, 2008Ventus Medical, Inc.Methods and devices for improving breathing in patients with pulmonary disease
US7662181Feb 16, 2010Pulmonx CorporationMethods and devices for use in performing pulmonary procedures
US7670282Mar 2, 2010Pneumrx, Inc.Lung access device
US7682332Jun 30, 2004Mar 23, 2010Portaero, Inc.Methods to accelerate wound healing in thoracic anastomosis applications
US7686013Mar 30, 2010Portaero, Inc.Variable resistance pulmonary ventilation bypass valve
US7691151Oct 24, 2006Apr 6, 2010Spiration, Inc.Articulable Anchor
US7717115Nov 25, 2003May 18, 2010Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US7726305Feb 12, 2008Jun 1, 2010Portaero, Inc.Variable resistance pulmonary ventilation bypass valve
US7735491Dec 8, 2005Jun 15, 2010Ventus Medical, Inc.Methods of treating respiratory disorders
US7735492Dec 8, 2005Jun 15, 2010Ventus Medical, Inc.Nasal respiratory devices
US7753052Jul 13, 2010Portaero, Inc.Intra-thoracic collateral ventilation bypass system
US7757692Jul 20, 2010Spiration, Inc.Removable lung reduction devices, systems, and methods
US7766891Aug 3, 2010Pneumrx, Inc.Lung device with sealing features
US7766938Aug 3, 2010Pneumrx, Inc.Pleural effusion treatment device, method and material
US7771472Nov 18, 2005Aug 10, 2010Pulmonx CorporationBronchial flow control devices and methods of use
US7775968Aug 17, 2010Pneumrx, Inc.Guided access to lung tissues
US7789083Sep 7, 2010Portaero, Inc.Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US7798147Jul 25, 2003Sep 21, 2010Pulmonx CorporationBronchial flow control devices with membrane seal
US7798148Dec 8, 2005Sep 21, 2010Ventus Medical, Inc.Respiratory devices
US7806120Jun 7, 2007Oct 5, 2010Ventus Medical, Inc.Nasal respiratory devices for positive end-expiratory pressure
US7811274Oct 12, 2010Portaero, Inc.Method for treating chronic obstructive pulmonary disease
US7814912Jun 29, 2005Oct 19, 2010Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US7824366Nov 2, 2010Portaero, Inc.Collateral ventilation device with chest tube/evacuation features and method
US7828789Nov 9, 2010Portaero, Inc.Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US7842061Dec 23, 2003Nov 30, 2010Spiration, Inc.Methods of achieving lung volume reduction with removable anchored devices
US7854228Dec 21, 2010Pulmonx CorporationBronchial flow control devices and methods of use
US7856979May 22, 2007Dec 28, 2010Ventus Medical, Inc.Nasal respiratory devices
US7875048Jan 25, 2011Spiration, Inc.One-way valve devices for anchored implantation in a lung
US7887585Mar 4, 2009Feb 15, 2011Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US7896008Mar 1, 2011Portaero, Inc.Lung reduction system
US7896887Mar 1, 2011Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US7909803Feb 18, 2009Mar 22, 2011Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US7927324Feb 18, 2009Apr 19, 2011Portaero, Inc.Aspirator and method for pneumostoma management
US7931641Apr 26, 2011Portaero, Inc.Visceral pleura ring connector
US7942931Aug 15, 2005May 17, 2011Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US7987852Feb 11, 2009Aug 2, 2011Ventus Medical, Inc.Nasal devices
US7992564Feb 24, 2010Aug 9, 2011Ventus Medical, Inc.Respiratory devices
US8020700Dec 5, 2008Sep 20, 2011Ventus Medical, Inc.Packaging and dispensing nasal devices
US8021320Sep 20, 2011Portaero, Inc.Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma
US8021385Sep 20, 2011Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8029492Oct 4, 2011Portaero, Inc.Method for treating chronic obstructive pulmonary disease
US8043301Oct 25, 2011Spiration, Inc.Valve loader method, system, and apparatus
US8061357Nov 22, 2011Ventus Medical, Inc.Adhesive nasal respiratory devices
US8062315 *Nov 22, 2011Portaero, Inc.Variable parietal/visceral pleural coupling
US8079368Dec 20, 2011Spiration, Inc.Bronchoscopic lung volume reduction method
US8104474Aug 23, 2005Jan 31, 2012Portaero, Inc.Collateral ventilation bypass system with retention features
US8136230Oct 10, 2008Mar 20, 2012Spiration, Inc.Valve loader method, system, and apparatus
US8142455Sep 12, 2008Mar 27, 2012Pneumrx, Inc.Delivery of minimally invasive lung volume reduction devices
US8157823Apr 17, 2012Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US8157837Jun 2, 2006Apr 17, 2012Pneumrx, Inc.Minimally invasive lung volume reduction device and method
US8163034Apr 24, 2012Portaero, Inc.Methods and devices to create a chemically and/or mechanically localized pleurodesis
US8177805Aug 4, 2011May 15, 2012Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8206684Jun 26, 2012Pulmonx CorporationMethods and devices for blocking flow through collateral pathways in the lung
US8215308Jul 10, 2012Ventus Medical, Inc.Sealing nasal devices for use while sleeping
US8220460Jul 17, 2012Portaero, Inc.Evacuation device and method for creating a localized pleurodesis
US8231581Jan 25, 2011Jul 31, 2012Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US8235046Sep 16, 2010Aug 7, 2012Ventus Medical, Inc.Nasal devices for use while sleeping
US8240309Nov 16, 2007Aug 14, 2012Ventus Medical, Inc.Adjustable nasal devices
US8251067Aug 16, 2010Aug 28, 2012Pulmonx CorporationBronchial flow control devices with membrane seal
US8252003Feb 18, 2009Aug 28, 2012Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8257381Dec 15, 2010Sep 4, 2012Spiration, Inc.One-way valve devices for anchored implantation in a lung
US8281557Oct 9, 2012Ventus Medical, Inc.Method of packaging and dispensing nasal devices
US8282660Oct 9, 2012Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US8291909Sep 17, 2010Oct 23, 2012Ventus Medical, Inc.Methods of treating a disorder by inhibiting expiration
US8302606Sep 17, 2010Nov 6, 2012Ventus Medical, Inc.Methods of treating a sleeping subject
US8302607Nov 17, 2011Nov 6, 2012Ventus Medical, Inc.Adhesive nasal respiratory devices
US8323230Jan 20, 2010Dec 4, 2012Portaero, Inc.Methods and devices to accelerate wound healing in thoracic anastomosis applications
US8336540Feb 12, 2009Dec 25, 2012Portaero, Inc.Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US8347880Jan 8, 2013Potaero, Inc.Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US8347881Jan 8, 2013Portaero, Inc.Pneumostoma management device with integrated patency sensor and method
US8348906Jan 8, 2013Portaero, Inc.Aspirator for pneumostoma management
US8357139Nov 4, 2008Jan 22, 2013Pulmonx CorporationMethods and devices for use in performing pulmonary procedures
US8365722Feb 18, 2009Feb 5, 2013Portaero, Inc.Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8365736Feb 5, 2013Ventus Medical, Inc.Nasal devices with respiratory gas source
US8388682Mar 5, 2013Pulmonx CorporationBronchial flow control devices and methods of use
US8414655Apr 9, 2013Spiration, Inc.Removable lung reduction devices, systems, and methods
US8430094Feb 18, 2009Apr 30, 2013Portaero, Inc.Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8444690Jan 12, 2011May 21, 2013Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US8453637Jun 4, 2013Portaero, Inc.Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8453638Feb 18, 2009Jun 4, 2013Portaero, Inc.One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8454708Jun 4, 2013Spiration, Inc.Articulable anchor
US8464708Feb 18, 2009Jun 18, 2013Portaero, Inc.Pneumostoma management system having a cosmetic and/or protective cover
US8474449Feb 18, 2009Jul 2, 2013Portaero, Inc.Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8474460Sep 17, 2010Jul 2, 2013Pulmonx CorporationImplanted bronchial isolation devices and methods
US8475389Jun 8, 2010Jul 2, 2013Portaero, Inc.Methods and devices for assessment of pneumostoma function
US8491602Feb 18, 2009Jul 23, 2013Portaero, Inc.Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US8506577Jul 6, 2012Aug 13, 2013Portaero, Inc.Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US8518053Feb 11, 2010Aug 27, 2013Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8603127Mar 8, 2012Dec 10, 2013Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8632605Sep 11, 2009Jan 21, 2014Pneumrx, Inc.Elongated lung volume reduction devices, methods, and systems
US8635365 *May 14, 2007Jan 21, 2014International Business Machines CorporationData processing system using matching engine and routing switch
US8647392Apr 26, 2012Feb 11, 2014Spiration, Inc.Articulable anchor
US8667973Nov 1, 2011Mar 11, 2014Spiration, Inc.Bronchoscopic lung volume reduction method
US8668707Sep 14, 2012Mar 11, 2014Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US8721734May 18, 2010May 13, 2014Pneumrx, Inc.Cross-sectional modification during deployment of an elongate lung volume reduction device
US8740921Sep 14, 2012Jun 3, 2014Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US8795241May 13, 2011Aug 5, 2014Spiration, Inc.Deployment catheter
US8875711May 27, 2011Nov 4, 2014Theravent, Inc.Layered nasal respiratory devices
US8876791Sep 15, 2010Nov 4, 2014Pulmonx CorporationCollateral pathway treatment using agent entrained by aspiration flow current
US8888800Mar 13, 2012Nov 18, 2014Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US8926647Mar 29, 2013Jan 6, 2015Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8932310Sep 14, 2012Jan 13, 2015Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US8956319Jul 20, 2012Feb 17, 2015Spiration, Inc.One-way valve devices for anchored implantation in a lung
US8974484Mar 6, 2013Mar 10, 2015Spiration, Inc.Removable lung reduction devices, systems, and methods
US8974527Mar 29, 2013Mar 10, 2015Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US8985116Jun 7, 2007Mar 24, 2015Theravent, Inc.Layered nasal devices
US8986336Jan 25, 2011Mar 24, 2015Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US9125639Nov 23, 2005Sep 8, 2015Pneumrx, Inc.Steerable device for accessing a target site and methods
US9173669Sep 11, 2009Nov 3, 2015Pneumrx, Inc.Enhanced efficacy lung volume reduction devices, methods, and systems
US9192403Dec 19, 2013Nov 24, 2015Pneumrx, Inc.Elongated lung volume reduction devices, methods, and systems
US9198669Dec 13, 2013Dec 1, 2015Spiration, Inc.Articulable anchor
US9211181Sep 24, 2012Dec 15, 2015Pulmonx CorporationImplant loading device and system
US9238113Sep 8, 2010Jan 19, 2016Theravent, Inc.Nasal respiratory devices for positive end-expiratory pressure
US9326873Dec 6, 2011May 3, 2016Spiration, Inc.Valve loader method, system, and apparatus
US9402632Apr 24, 2014Aug 2, 2016Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US9402633Mar 13, 2014Aug 2, 2016Pneumrx, Inc.Torque alleviating intra-airway lung volume reduction compressive implant structures
US9402971Jan 23, 2014Aug 2, 2016Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US20020095209 *Feb 8, 2002Jul 18, 2002Gholam-Reza Zadno-AziziBody fluid flow control device
US20020112729 *Feb 21, 2001Aug 22, 2002Spiration, Inc.Intra-bronchial obstructing device that controls biological interaction with the patient
US20030070682 *Oct 10, 2002Apr 17, 2003Wilson Peter M.Bronchial flow control devices and methods of use
US20030070683 *Nov 22, 2002Apr 17, 2003Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20030158515 *Dec 11, 2002Aug 21, 2003Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US20030183235 *Apr 17, 2003Oct 2, 2003Spiration, Inc.Bronchial obstruction device deployment system and method
US20030195385 *Apr 16, 2002Oct 16, 2003Spiration, Inc.Removable anchored lung volume reduction devices and methods
US20030199972 *Apr 18, 2003Oct 23, 2003Gholam-Reza Zadno-AziziBody fluid flow control device
US20030212412 *May 9, 2002Nov 13, 2003Spiration, Inc.Intra-bronchial obstructing device that permits mucus transport
US20030212452 *Jun 3, 2003Nov 13, 2003Gholam-Reza Zadno-AziziBody fluid flow control device
US20030216769 *May 17, 2002Nov 20, 2003Dillard David H.Removable anchored lung volume reduction devices and methods
US20040010209 *Jul 15, 2002Jan 15, 2004Spiration, Inc.Device and method for measuring the diameter of an air passageway
US20040039250 *May 28, 2003Feb 26, 2004David TholfsenGuidewire delivery of implantable bronchial isolation devices in accordance with lung treatment
US20040055606 *Jul 25, 2003Mar 25, 2004Emphasys Medical, Inc.Bronchial flow control devices with membrane seal
US20040059263 *Sep 24, 2002Mar 25, 2004Spiration, Inc.Device and method for measuring the diameter of an air passageway
US20040060563 *Jul 25, 2003Apr 1, 2004Alan RapackiBronchial flow control devices and methods of use
US20040074491 *Aug 20, 2003Apr 22, 2004Michael HendricksenDelivery methods and devices for implantable bronchial isolation devices
US20040078054 *Jul 28, 2003Apr 22, 2004Broncus Technologies, Inc.Method for lung volume reduction
US20040089306 *May 28, 2003May 13, 2004Ronald HundertmarkDevices and methods for removing bronchial isolation devices implanted in the lung
US20040134487 *Nov 6, 2003Jul 15, 2004Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20040143282 *Dec 23, 2003Jul 22, 2004Dillard David H.Methods of achieving lung volume reduction with removable anchored devices
US20040148035 *Nov 25, 2003Jul 29, 2004Michael BarrettDelivery methods and devices for implantable bronchial isolation devices
US20040194779 *Apr 19, 2004Oct 7, 2004Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US20040200484 *Apr 8, 2003Oct 14, 2004Springmeyer Steven C.Bronchoscopic lung volume reduction method
US20040206349 *May 17, 2004Oct 21, 2004Alferness Clifton A.Removable lung reduction devices, systems, and methods
US20040210248 *Mar 12, 2003Oct 21, 2004Spiration, Inc.Apparatus, method and assembly for delivery of intra-bronchial devices
US20040211412 *May 17, 2004Oct 28, 2004Alferness Clifton A.Removable lung reduction devices, systems, and method
US20040225254 *Apr 27, 2004Nov 11, 2004Don TanakaLocalized pleurodesis chemical delivery
US20040237966 *May 20, 2004Dec 2, 2004Don TanakaMethods and devices to assist pulmonary decompression
US20040243140 *May 18, 2004Dec 2, 2004Alferness Clifton A.Collapsible intra-bronchial valve devices
US20040243393 *May 29, 2003Dec 2, 2004Microsoft CorporationSemantic object synchronous understanding implemented with speech application language tags
US20040244803 *May 24, 2004Dec 9, 2004Don TanakaIntra-thoracic collateral ventilation bypass system
US20050025816 *Jun 30, 2004Feb 3, 2005Don TanakaMethods and devices to accelerate wound healing in thoracic anastomosis applications
US20050033310 *May 17, 2004Feb 10, 2005Alferness Clifton A.Intra-bronchial valve devices
US20050033344 *Sep 3, 2004Feb 10, 2005Dillard David H.One-way valve devices for anchored implantation in a lung
US20050051163 *Nov 6, 2003Mar 10, 2005Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20050066974 *May 28, 2003Mar 31, 2005Antony FieldsModification of lung region flow dynamics using flow control devices implanted in bronchial wall channels
US20050137714 *Dec 22, 2003Jun 23, 2005Gonzalez Hugo X.Bronchoscopic repair of air leaks in a lung
US20050145253 *Mar 2, 2005Jul 7, 2005Emphasys Medical, Inc., A Delaware CorporationBronchial flow control devices and methods of use
US20050166925 *Mar 28, 2005Aug 4, 2005Emphasys Medical, Inc., A California CorporationBronchial flow control devices and methods of use
US20050178389 *Jan 26, 2005Aug 18, 2005Shaw David P.Disease indications for selective endobronchial lung region isolation
US20050196344 *Feb 25, 2005Sep 8, 2005Mccutcheon JohnMethods and devices for blocking flow through collateral pathways in the lung
US20050288549 *Jun 14, 2005Dec 29, 2005Pneumrx, Inc.Guided access to lung tissues
US20050288684 *Jun 14, 2005Dec 29, 2005Aronson Nathan AMethod of reducing collateral flow in a portion of a lung
US20060004305 *Jun 29, 2005Jan 5, 2006George Robert MDelivery methods and devices for implantable bronchial isolation devices
US20060009801 *Jul 8, 2005Jan 12, 2006Mcgurk ErinPleural effusion treatment device, method and material
US20060020347 *Mar 8, 2005Jan 26, 2006Michael BarrettImplanted bronchial isolation devices and methods
US20060025815 *Jul 8, 2005Feb 2, 2006Mcgurk ErinLung device with sealing features
US20060030863 *Jul 20, 2005Feb 9, 2006Fields Antony JImplanted bronchial isolation device delivery devices and methods
US20060032497 *Jul 11, 2005Feb 16, 2006Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US20060074382 *Aug 15, 2005Apr 6, 2006Gonzalez Hugo XDevice and method for intra-bronchial provision of a therapeutic agent
US20060076023 *Nov 29, 2005Apr 13, 2006Emphasys Medical, Inc., A Delaware CorporationBronchial flow control devices and methods of use
US20060107956 *Nov 18, 2005May 25, 2006Hendricksen Michael JBronchial flow control devices and methods of use
US20060107961 *Nov 19, 2004May 25, 2006Don TanakaLocalized pleurodesis evacuation device
US20060118125 *Nov 19, 2004Jun 8, 2006Don TanakaPulmonary drug delivery
US20060118126 *Nov 19, 2004Jun 8, 2006Don TanakaMethods and devices for controlling collateral ventilation
US20060124126 *Dec 10, 2004Jun 15, 2006Don TanakaCollateral ventilation device with chest tube/evacuation features
US20060144398 *Dec 8, 2005Jul 6, 2006Rajiv DoshiRespiratory devices
US20060150978 *Dec 8, 2005Jul 13, 2006Ventus Medical, Inc.Methods of treating respiratory disorders
US20060150979 *Dec 8, 2005Jul 13, 2006Ventus Medical, Inc.Nasal respiratory devices
US20060155217 *Oct 26, 2005Jul 13, 2006Devore Lauri JDevice and method for measuring the diameter of an air passageway
US20060167416 *Nov 23, 2005Jul 27, 2006Mark MathisSteerable device for accessing a target site and methods
US20060174870 *Mar 30, 2006Aug 10, 2006Deem Mark EMethods and devices for use in performing pulmonary procedures
US20060200076 *May 3, 2006Sep 7, 2006Gonzalez Hugo XDevice and method for intra-bronchial provision of a therapeutic agent
US20060206147 *May 3, 2006Sep 14, 2006Devore Lauri JIntra-bronchial obstruction device that provides a medicant intra-bronchially to the patient
US20060235432 *May 3, 2006Oct 19, 2006Devore Lauri JIntra-bronchial obstructing device that controls biological interaction with the patient
US20060235467 *May 2, 2006Oct 19, 2006Devore Lauri JRemovable anchored lung volume reduction device and methods
US20060249164 *May 3, 2006Nov 9, 2006Springmeyer Steven CBronchoscopic lung volume reduction method
US20060283462 *Aug 25, 2006Dec 21, 2006Fields Antony JMethods and devices for inducing collapse in lung regions fed by collateral pathways
US20070051372 *Aug 23, 2005Mar 8, 2007Don TanakaCollateral ventilation bypass system with retention features
US20070163598 *Jan 17, 2006Jul 19, 2007Asia ChangVariable resistance pulmonary ventilation bypass valve
US20070185531 *Apr 10, 2007Aug 9, 2007Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US20070221230 *Jun 2, 2006Sep 27, 2007David ThompsonMinimally invasive lung volume reduction device and method
US20070232992 *Oct 24, 2006Oct 4, 2007James KutskoArticulable anchor
US20070235846 *Apr 1, 2006Oct 11, 2007Stats Chippac Ltd.Integrated circuit package system with net spacer
US20070270776 *Aug 6, 2007Nov 22, 2007Respira, Inc.Lung reduction system
US20070283962 *Jun 7, 2007Dec 13, 2007Ventus Medical, Inc.Layered nasal devices
US20080041373 *Jun 7, 2007Feb 21, 2008Ventus Medical, Inc.Nasal devices
US20080052727 *May 14, 2007Feb 28, 2008International Business Machines CorporationData processing system using matching engine and routing switch
US20080072914 *Aug 24, 2007Mar 27, 2008Hendricksen Michael JBronchial Isolation Devices for Placement in Short Lumens
US20080119866 *Jul 19, 2007May 22, 2008Alferness Clifton ARemovable anchored lung volume reduction devices and methods
US20080142018 *Nov 16, 2007Jun 19, 2008Ventus Medical, Inc.Nasal device applicators
US20080178874 *Nov 16, 2007Jul 31, 2008Ventus Medical, Inc.Adjustable nasal devices
US20080188809 *Apr 7, 2008Aug 7, 2008Portaero, Inc.Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US20080221470 *Mar 7, 2008Sep 11, 2008Elliot SatherRespiratory sensor adapters for nasal devices
US20080249503 *Jun 4, 2008Oct 9, 2008Fields Antony JMethods and devices for lung treatment
US20080281151 *Feb 21, 2008Nov 13, 2008Portaero, Inc.Pulmonary pleural stabilizer
US20080281433 *Feb 21, 2008Nov 13, 2008Portaero, Inc.Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080283065 *Feb 21, 2008Nov 20, 2008Portaero, Inc.Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung
US20080287878 *Feb 21, 2008Nov 20, 2008Portaero, Inc.Pulmonary visceral pleura anastomosis reinforcement
US20080295829 *Feb 21, 2008Dec 4, 2008Portaero, Inc.Bridge element for lung implant
US20090050144 *Jun 18, 2008Feb 26, 2009Ryan Kendall PierceAdhesive nasal respiratory devices
US20090076622 *Sep 12, 2008Mar 19, 2009Pneumrx, Inc.Delivery of Minimally Invasive Lung Volume Reduction Devices
US20090099530 *Oct 10, 2008Apr 16, 2009Martin Neal AdamsValve loader method, system, and apparatus
US20090145441 *Dec 8, 2008Jun 11, 2009Rajiv DoshiDelayed resistance nasal devices and methods of use
US20090145788 *Dec 5, 2008Jun 11, 2009Rajiv DoshiPackaging and dispensing nasal devices
US20090182369 *Mar 4, 2009Jul 16, 2009Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US20090188493 *Feb 11, 2009Jul 30, 2009Rajiv DoshiNasal devices
US20090194109 *Feb 2, 2009Aug 6, 2009Rajiv DoshiCpap interface and backup devices
US20090205641 *Feb 12, 2009Aug 20, 2009Portaero, Inc.Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US20090205643 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Accelerated two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090205644 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US20090205645 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Pneumostoma management method for the treatment of chronic obstructive pulmonary disease
US20090205646 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205648 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US20090205649 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205650 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US20090205651 *Feb 18, 2009Aug 20, 2009Portaero, Inc.One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090205665 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Methods and devices for follow-up care and treatment of a pneumostoma
US20090205667 *Apr 22, 2009Aug 20, 2009Spiration, Inc.Removable lung reduction devices, systems, and methods
US20090209856 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090209909 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Percutaneous single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US20090209924 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US20090209936 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Aspirator and method for pneumostoma management
US20090209971 *Feb 18, 2009Aug 20, 2009Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US20090255537 *Jun 24, 2009Oct 15, 2009PulmonxDisease indications for selective endobronchial lung region isolation
US20090292262 *Apr 10, 2009Nov 26, 2009Martin Neal AdamsValve loader method, system, and apparatus
US20090308398 *Jun 16, 2009Dec 17, 2009Arthur FerdinandAdjustable resistance nasal devices
US20100129420 *Jan 20, 2010May 27, 2010Portaero, Inc.Methods and devices to accelerate wound healing in thoracic anastomosis applications
US20100147294 *Feb 19, 2010Jun 17, 2010Portaero, Inc.Devices and methods to maintain the patency of an opening relative to parenchymal tissue of the lung
US20100147295 *Feb 19, 2010Jun 17, 2010Portaero, Inc.Devices and methods to create and maintain the patency of an opening relative to parenchymal tissue of the lung
US20100147308 *Feb 24, 2010Jun 17, 2010Rajiv DoshiRespiratory devices
US20100170507 *Jan 8, 2010Jul 8, 2010Portaero, Inc.Pneumostoma management device with integrated patency sensor and method
US20100204707 *Feb 11, 2010Aug 12, 2010Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US20100256714 *Mar 10, 2010Oct 7, 2010Springmeyer Steven CBronchoscopic lung volume reduction method
US20100262071 *Apr 5, 2010Oct 14, 2010James KutskoArticulable anchor
US20100286544 *Jun 8, 2010Nov 11, 2010Portaero, Inc.Methods and devices for assessment of pneumostoma function
US20100305715 *May 18, 2010Dec 2, 2010Pneumrx, Inc.Cross-Sectional Modification During Deployment of an Elongate Lung Volume Reduction Device
US20100326447 *Sep 8, 2010Dec 30, 2010Bryan LoomasNasal respiratory devices for positive end-expiratory pressure
US20110005520 *Sep 17, 2010Jan 13, 2011Rajiv DoshiQuiet nasal respiratory devices
US20110005528 *Sep 16, 2010Jan 13, 2011Rajiv DoshiNasal devices with respiratory gas source
US20110005529 *Sep 17, 2010Jan 13, 2011Rajiv DoshiMethods of treating a sleeping subject
US20110005530 *Sep 17, 2010Jan 13, 2011Rajiv DoshiMethods of treating a disorder by inhibiting expiration
US20110017207 *Jan 27, 2011Pulmonx CorporationBronchial flow control devices with membrane seal
US20110054632 *Jul 1, 2010Mar 3, 2011Spiration, Inc.Removable lung reduction devices, systems, and methods
US20110056499 *Sep 16, 2010Mar 10, 2011Rajiv DoshiSealing nasal devices for use while sleeping
US20110067708 *Sep 16, 2010Mar 24, 2011Rajiv DoshiNasal devices for use while sleeping
US20110067709 *Nov 29, 2010Mar 24, 2011Rajiv DoshiNasal respiratory devices
US20110079221 *Dec 15, 2010Apr 7, 2011Spiration, Inc.One-way valve devices for anchored implantation in a lung
US20110092767 *Sep 17, 2010Apr 21, 2011Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US20110108041 *May 12, 2011Elliot SatherNasal devices having a safe failure mode and remotely activatable
US20110118669 *May 19, 2011Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US20110130834 *Jun 2, 2011Pulmonx CorporationBronchial flow control devices and methods of use
US20110203598 *Aug 25, 2011Favet Michael LNasal devices including layered nasal devices and delayed resistance adapters for use with nasal devices
US20110208228 *Aug 25, 2011Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US20110226238 *Sep 17, 2010Sep 22, 2011Pulmonx CorporationImplanted bronchial isolation devices and methods
CN102580171A *Jan 30, 2012Jul 18, 2012先健科技(深圳)有限公司Bronchus flap and manufacturing method thereof
CN103750920A *Dec 31, 2013Apr 30, 2014先健科技(深圳)有限公司Unidirectional flap
EP2954874A2Apr 6, 2010Dec 16, 2015Spiration Inc.Deployment catheter with marker bands
WO2010118056A1Apr 6, 2010Oct 14, 2010Spiration, Inc.Valve loader method, system, and apparatus
Classifications
U.S. Classification606/108
International ClassificationA61M16/00, A61M15/00, A61M16/04, A61B, A61B17/24, A61D1/12, A61F11/00, A61B17/12, A61B17/00
Cooperative ClassificationA61B2017/12054, A61M16/0404, A61B17/12172, A61B17/12022, A61B2017/1205, A61B17/12104, A61B17/12036
European ClassificationA61B17/12P7W1, A61B17/12P1P, A61B17/12P5A, A61B17/12P
Legal Events
DateCodeEventDescription
Sep 11, 2001ASAssignment
Owner name: SPIRATION, INC., WASHINGTON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ALFERNESS, CLIFTON A.;GONZALEZ, HUGO X.;DILLARD, DAVID H.;REEL/FRAME:012171/0164;SIGNING DATES FROM 20010829 TO 20010907